New Search

If you are not happy with the results below please do another search

2035 search results for:

1561

Biomarker identified to aid in prognosis of paediatric ependymomas

A multi-institutional group of researchers, led by investigators at Children’s Hospital Los Angeles and the University of Michigan, have identified a simple and inexpensive tool for assessing the prognosis of paediatric brain tumours called ependymomas. Their study, which demonstrates the epigenetic mechanism behind these tumours, may offer future opportunities for novel therapeutic options. Childhood posterior […]

1562

Launch of Shimadzu European Innovation Center

Shimadzu has introduced its European Innovation Center in Duisburg, Germany. This innovations-oriented Think Tank combines academic-scientific and technological know-how to use Shimadzu’s expertise to provide even more customer-focused service.  It merges the cutting-edge analytical technologies of Shimadzu with the game-changing topics in markets and science covered by opinion leaders, strategic thinkers and scientific experts in […]

1563

Shared genetic origin for MND and schizophrenia

Researchers from Trinity College Dublin have shown for the first time that Motor Neurone Disease (MND) — also known as Amyotrophic Lateral Sclerosis (ALS) — and schizophrenia have a shared genetic origin, indicating that the causes of these diverse conditions are biologically linked. By analysing the genetic profiles of almost 13,000 MND cases and over […]

1564

How 1 000 new genetic variants were discovered in blood groups

1 000 new mutations in the blood group genes: that is what physician and former programmer Mattias Möller found in his research study in which he developed new software and investigated blood group genes in 2 504 people. The international project 1000 Genomes is so far the world’s largest mapping of human genetic variants. By […]

1565

New eye test detects earliest signs of glaucoma

The Wellcome-funded diagnostic – developed by researchers at University College London (UCL) and the Western Eye Hospital – allows doctors to see individual nerve cell death in the back of the eye. Early detection means doctors can start treatment before sight loss begins. The test also has potential for early diagnosis of other degenerative neurological […]

1566

DNA methylation biomarker for prostate cancer shows promise for accurately determining patient risk

Prostate-specific antigen (PSA) and other biomarkers are essential tools for diagnosing and monitoring prostate cancer. However, biomarkers to selectively identify patients with high risk of recurrence, those who might benefit from intervention, and those who can safely choose active surveillance, are lacking. A report describes a biomarker, PITX2 DNA methylation, which is capable of distinguishing […]

1567

Gene discovered to cause rare, severe neurological disease

The scientists from the Montreal Neurological Institute and Hospital at McGill University, led by Peter McPherson, along with collaborators in Saudi Arabia, Jordan, Germany, and at SickKids Hospital and the University of Toronto, have discovered that a severe form of epileptic encephalopathy is caused by recessive loss-of-function mutations in the gene DENND5A. Epileptic encephalopathy is […]

1568

Vitamin D deficiency may indicate cardiovascular disease in overweight and obese children

In overweight and obese children and adolescents, vitamin D deficiency is associated with early markers of cardiovascular disease, a new study reports. "Paediatric obesity affects 17 percent of infants, children, and adolescents ages 2 to 19 in the United States, and obesity is a risk factor for vitamin D deficiency. These findings suggest that vitamin […]

1569

Molecular ‘on switch’ could point to treatments for paediatric brain tumour

Massachusetts General Hospital (MGH) researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common paediatric brain tumour. The team also identifies potential targets for future treatments. “We set out to find the most important regulators of gene expression programs in medulloblastoma,” […]

1570

Study supports lower cut-off point for defining pre-diabetes

The health risks and mortality associated with pre-diabetes seem to increase at the lower cut-off point for blood sugar levels recommended by some guidelines, finds a large study published. Pre-diabetes is a ‘pre-diagnosis’ of diabetes — when a person’s blood glucose level is higher than normal, but not high enough to be considered diabetes. If […]